Tag Archives: Kerrisdale

Kerrisdale Provides Less than Sage Advice

On March 23, a number of NeuroPerspective subscribers and sources forwarded to us a ‘report’ prepared by Kerrisdale Capital on SAGE Therapeutics. Subheaded ‘Overhyped Lead Drug Headed for Failure,’ it gave the illusion of a detailed, seemingly well-researched critique of … Continue reading

Posted in BioFollies, Biotech, Muddled Media | Tagged , , , , | Leave a comment